129 research outputs found

    АвтоматичСская оптимизация тСхнологичСского комплСкса обогащСния ΠΆΠ΅Π»Π΅Π·Π½Ρ‹Ρ… Ρ€ΡƒΠ΄ ΠΏΠΎ сигналам ΠΌΠ°Π³Π½ΠΈΡ‚Π½ΠΎΠΉ ΠΈΠ½Π΄ΡƒΠΊΡ†ΠΈΠΈ сСпаратора

    Get PDF
    Recombinant antibodies can be used to diagnose, treat and prevent disease by exploiting their specific antigen-binding activities. A large number of drugs currently in development are recombinant antibodies and most of these are produced in cultured rodent cells. Although such cells produce authentic functional products, they are expensive, difficult to scale-up and may contain human pathogens. Plants represent a cost-effective, convenient and safe alternative production system and are slowly gaining acceptance. Five plant-derived therapeutic recombinant antibodies (plantibodies) are undergoing clinical evaluation, three of which can be used as prophylactics

    Molecular farming of human tissue transglutaminase in tobacco plants

    No full text
    In this study we have utilized Nicotiana tabacum with a molecular farming purpose in attempt of producing transgenic plants expressing the human tissue transglutaminase (htTG). Three plant expression constructs were used enabling targeting and accumulation of the recombinant protein into the plant cell cytosol (cyto), the chloroplasts (chl) and the apoplastic space (apo). Analysis of transgenic T(0) plants revealed that recombinant htTG was detectable in all three transgenic lines and the accumulation levels were in a range of 18-75 mu g/g of leaf material. In the T(1) generation, the recombinant htTG was still expressed at high level and a significant catalytic activity was detected into the leaf protein extracts. Southern blot analyses revealed that apo and chl plants of T(1) generation possess a high copy number of the recombinant htTG in their genome, while the cyto plants carry a single copy

    ΠŸΡ€Π°Π²ΠΎΠ²Ρ– засади здійснСння Π΄Ρ–ΡΠ»ΡŒΠ½ΠΎΡΡ‚Ρ– Π·Ρ– ΡΠΏΡ–Π»ΡŒΠ½ΠΎΠ³ΠΎ інвСстування

    Get PDF
    We describe the expression of the bispecific antibody biscFv2429 in transgenic suspension culture cells and tobacco plants. biscFv2429 consists of two single chain antibodies, scFv24 and scFv29, connected by the Trichoderma reesi cellobiohydrolase I linker. biscFv2429 binds two epitopes of tobacco mosaic virus (TMV): the scFv24 domain recognizes neotopes of intact virions, and the scFv29 domain recognizes a cryptotope of the TMV coat protein monomer. biscFv2429 was functionally expressed either in the cytosol (biscFv2429-cyt) or targeted to the apoplast using a murine leader peptide sequence (biscFv2429-apoplast). A third construct contained the C-terminal KDEL sequence for retention in the ER (biscFv2429-KDEL). Levels of cytoplasmic biscFv2429 expression levels were low. The highest levels of antibody expression were for apoplast targeted biscFv2429-apoplast and ER retained biscFv2429-KDEL, which reached a maximum expression level of 1.65% total soluble protein in transgenic plants. P lant expressed biscFv2429 retained both epitope specificities, and bispecificity and bivalency were confirmed by ELISA and surface plasmon resonance analysis. This study establishes plant cells as an expression system for bispecific single chain antibodies for use in medical and biological applications

    Бвязь микроэлСмСнтного состава Spirodela polyrhiza (L.) Schleid со срСдой Π΅Π³ΠΎ обитания

    Get PDF
    Plants and plant cell cultures have been evaluated over the past two decades as alternative production platforms for biopharmaceuticals. A large number of candidate proteins has been successfully produced in a range of plant species and the most advanced products are currently progressing through the clinical development stages. We first discuss principles for the production of plant-made pharmaceuticals including plant transformation procedures, post-translational modifications, and downstream processing. We then highlight some of the most advanced plant-made biopharmaceuticals currently in clinical development for human medical use

    Π‘ΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€Π½Ρ‹Ρ… ΠΊΠΎΠΌΠΏΠΎΠ·ΠΈΡ†ΠΈΠΎΠ½Π½Ρ‹Ρ… ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΠΎΠ² с Π½Π΅ΠΏΡ€Π΅Ρ€Ρ‹Π²Π½Ρ‹ΠΌ Π°Ρ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π°Ρ€Π°ΠΌΠΈΠ΄Π½Ρ‹ΠΌ Π²ΠΎΠ»ΠΎΠΊΠ½ΠΎΠΌ для примСнСния Π² Π°Π΄Π΄ΠΈΡ‚ΠΈΠ²Π½Ρ‹Ρ… тСхнологиях

    Get PDF
    Π’ Π΄Π°Π½Π½ΠΎΠΉ Ρ€Π°Π±ΠΎΡ‚Π΅ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ исслСдованиС создания ΠΊΠΎΠΌΠΏΠΎΠ·ΠΈΡ†ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° Π½Π° ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€Π½ΠΎΠΉ основС с Π½Π΅ΠΏΡ€Π΅Ρ€Ρ‹Π²Π½Ρ‹ΠΌ Π°Ρ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π°Ρ€Π°ΠΌΠΈΠ΄Π½ΠΎΠ³ΠΎ Π²ΠΎΠ»ΠΎΠΊΠ½Π° для примСнСния Π² Π°Π΄Π΄ΠΈΡ‚ΠΈΠ²Π½Ρ‹Ρ… тСхнологиях. ΠžΠΏΠΈΡΠ°Π½Ρ‹ тСхнологичСскиС особСнности процСсса ΠΌΠΎΠ΄ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΈ повСрхности Π°Ρ€Π°ΠΌΠΈΠ΄Π½ΠΎΠ³ΠΎ Π²ΠΎΠ»ΠΎΠΊΠ½Π°. ИсслСдовано влияниС ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° ΠΌΠΎΠ΄ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΈ повСрхности Π½Π° Π°Π΄Π³Π΅Π·ΠΈΠΎΠ½Π½Ρ‹Π΅ свойства ΠΏΠΎΠ»ΡƒΡ‡Π°Π΅ΠΌΠΎΠ³ΠΎ ΠΊΠΎΠΌΠΏΠΎΠ·ΠΈΡ†ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π°

    Π Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠ° матСматичСской ΠΌΠΎΠ΄Π΅Π»ΠΈ процСсса гидроочистки Π²Π°ΠΊΡƒΡƒΠΌΠ½ΠΎΠ³ΠΎ дистиллята

    Get PDF
    Plants are now gaining widespread acceptance as a general platform for the large-scale production of recombinant proteins. The first plant-derived recombinant pharmaceutical proteins are reaching the final stages of clinical evaluation, and many more are in the development pipeline. Over the past two years, there have been some notable technological advances in this flourishing area of applied biotechnology, as shown by the continuing commercial development of novel plant-based expression platforms. There has also been significant success in tackling some of the limitations of plant bioreactors, such as low yields and inconsistent product quality, that have limited the approval of plant-derived pharmaceuticals

    ΠžΡ†Π΅Π½ΠΊΠ° возмоТности ΠΌΠ΅Ρ‚ΠΎΠ΄Π° КИМов для Ρ€Π΅ΡˆΠ΅Π½ΠΈΡ Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π½Ρ‹Ρ… Π·Π°Π΄Π°Ρ‡ ΠΏΠΎ измСнСнию структуры ΠΈ ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€ΠΎΠ² Ρ‚Π΅ΠΏΠ»ΠΎΠ²Ρ‹Ρ… схСм ПВУ АЭБ

    Get PDF
    ΠžΠ±ΡŠΠ΅ΠΊΡ‚ΠΎΠΌ исслСдования Π΄ΠΈΠΏΠ»ΠΎΠΌΠ½ΠΎΠΉ Ρ€Π°Π±ΠΎΡ‚Ρ‹ ΡΠ²Π»ΡΡŽΡ‚ΡΡ экспрСсс-ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ Ρ€Π΅ΡˆΠ΅Π½ΠΈΡ Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π½Ρ‹Ρ… Π·Π°Π΄Π°Ρ‡ ΠΏΠΎ измСнСнию структуры Ρ‚Π΅ΠΏΠ»ΠΎΠ²Ρ‹Ρ… схСм ПВУ АЭБ. ЦСлью Ρ€Π°Π±ΠΎΡ‚Ρ‹ являСтся выявлСниС ΡΡ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ ΠΎΡ†Π΅Π½ΠΊΠΈ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² расчСтов Ρ‚Π΅ΠΏΠ»ΠΎΠ²Ρ‹Ρ… схСм экспрСсс-ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌΠΈ. ΠŸΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈΡΡŒ Π²Π°Ρ€ΠΈΠ°Π½Ρ‚Π½Ρ‹Π΅ ΡΡ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ расчСты ΠΏΡ€ΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΈ структуры ΠΈ ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€ΠΎΠ² Ρ‚Π΅ΠΏΠ»ΠΎΠ²Ρ‹Ρ… схСм.The object of the research thesis are rapid methods for solving specific problems of restructuring the thermal circuit Vocational plant. The aim is to identify the comparative evaluation of results of calculations of thermal schemes express methods. Were variant comparative calculations when changing the structure and parameters of thermal schemes

    ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π±ΡƒΡ€ΠΎΠ²Ρ‹Ρ… шламов Π² ΠΈΠ·Π³ΠΎΡ‚ΠΎΠ²Π»Π΅Π½ΠΈΠΈ ΡΡ‚Ρ€ΠΎΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΠΎΠ²

    Get PDF
    Thrombomodulin is a membrane-bound protein that plays an active role in the blood coagulation system by binding thrombin and initiating the protein C anticoagulant pathway. Solulin (TM) is a recombinant soluble derivative of human thrombomodulin. It is used for the treatment of thrombotic disorders. To evaluate the production of this pharmaceutical protein in plants, expression vectors were generated using four different N-terminal signal peptides. Immunoblot analysis of transiently transformed tobacco leaves showed that intact Solulin (TM) could be detected using three of these signal peptides. Furthermore transgenic tobacco plants and BY2 cells producing Solulin (TM) were generated. Immunoblot experiments showed that Solulin (TM) accumulated to maximum levels of 115 and 27 mu g g(-1)supercript stop plant material in tobacco plants and BY2 cells, respectively. Activity tests performed on the culture supernatant of transformed BY2 cells showed that the secreted Solulin (TM) was functional. In contrast, thrombomodulin activity was not detected in total soluble protein extracts from BY2 cells, probably due to inhibitory effects of substances in the cell extract. N-terminal sequencing was carried out on partially purified Solulin (TM) from the BY2 culture supernatant. The sequence was identical to that of Solulin (TM) produced in Chinese hamster ovary cells, confirming correct processing of the N-terminal signal peptide. We have demonstrated that plants and plant cell cultures can be used as alternative systems for the production of an active recombinant thrombomodulin derivative

    ПСнноС ΠΏΠΎΠΆΠ°Ρ€ΠΎΡ‚ΡƒΡˆΠ΅Π½ΠΈΠ΅: особСнности Π² соврСмСнных условиях

    Get PDF
    Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ ΠΏΠΎΠΊΠ°Π·Π°Π½Ρ‹ прСимущСства систСм ΠΏΠ΅Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠΆΠ°Ρ€ΠΎΡ‚ΡƒΡˆΠ΅Π½ΠΈΡ. РассмотрСны соврСмСнныС Ρ‚Π΅Π½Π΄Π΅Π½Ρ†ΠΈΠΈ Π² ΠΏΠ΅Π½Π½ΠΎΠΌ ΠΏΠΎΠΆΠ°Ρ€ΠΎΡ‚ΡƒΡˆΠ΅Π½ΠΈΠΈ. ΠŸΡ€ΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ нСдостатки ΠΏΠ΅Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠΆΠ°Ρ€ΠΎΡ‚ΡƒΡˆΠ΅Π½ΠΈΡ, обусловлСнныС систСмой дозирования пСнообразоватСля. РассмотрСны Π²ΠΈΠ΄Ρ‹ Π΄ΠΎΠ·Π°Ρ‚ΠΎΡ€ΠΎΠ² ΠΈ ΠΏΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½Π° элСктронная систСма дозирования "Π‘ΠΏΡ€ΡƒΡ‚-Π‘Π”"
    • …
    corecore